Dr Bernie Garrett – Professor Timothy Caulfield | Revealing the Risks of Alternative Medicine
Alternative healthcare is growing in popularity, but like all healthcare, the use of such therapies is not risk-free. Dr Bernie Garrett of the University of British Colombia, Canada, works with colleague Professor Timothy Caulfield from the University of Alberta, to provide a voice of reason in the world of alternative medicine. While trying to understand what makes people choose these options, they are also shedding light on the risks associated with using such unconventional treatments.
A Safe Option?
Alternative healthcare, sometimes referred to as ‘complementary’ or ‘traditional’ medicine, encompasses a wide range of different treatments and therapies, including Acupuncture, Homoeopathy, Reiki, Chiropractic, Herbal Medicines, and Nutritional Supplements. The prevailing belief among the public is that alternative healthcare is safe with minimal risks, yet there is a dearth of evidence regarding its actual risks.
Over the last twenty years, there has been substantial growth in the alternative healthcare industry within economically advanced nations. This expansion has sparked research into the drivers and factors influencing its adoption. No longer confined to a niche market, the alternative healthcare industry has evolved into a significant economic sector.
Dr Bernie Garrett is based at the University of British Colombia, Canada, whilst his colleague Professor Timothy Caulfield is Research Director at the Health Law Institute at the University of Alberta. They collaborate to share knowledge and insights into complementary and alternative medicine while working to identify the associated risks. They are also interested in exploring the individual personality traits and demographics associated with a higher likelihood of someone opting for alternative medicine.
A Booming Industry
Garrett and Caulfield highlight that in the USA alone, more than $30 billion was spent on alternative therapies in 2016, with 17% of Americans having tried an alternative therapy during that year. Garrett adds that in Canada, where he is based and carries out most of his research, about 70 to 80% of the population report having used an alternative therapy on at least one or more occasions in 2016, spending over $8 billion. He adds that research suggests that globally, the alternative medicine and healthcare market will be worth an astonishing $210 billion by 2026.
They note that alternative medicine use may be helpful, or even just benign – at best. However, there is a worrying move towards more people engaging in potentially dangerous alternative health behaviours, like choosing experimental or unsafe therapeutics or opting for alternative practices in preference to effective medical treatments. Garrett highlights a recent study carried out at Yale that revealed how cancer patients choosing alternative healthcare instead of conventional medicine experienced elevated mortality rates. He also notes instances of highly hazardous alternative health practices receiving attention in news headlines, like the case of an Alberta couple whose son tragically succumbed to meningitis following treatment with natural remedies. Although the level of risk associated with healthcare, in general, can be challenging to quantify, clinicians must strike a balance between the intended positive outcome and any potential harm, supported by up-to-date knowledge and a firm evidence base. This is not always the case in alternative medicine.
Identifying Risks: The Delphi Process
There has been little research investigating the risks linked with opting for alternative healthcare. Dr Garrett, Professor Caulfield, and colleagues set out to identify and classify the risks associated with alternative therapies in Canada. In 2020, they conducted a Delphi study where they utilised the skills of 17 healthcare and legal experts comprising of physicians, nurses, pharmacists, physiotherapists, social workers, lawyers with expertise in harm, injury and case law, an epidemiologist, a chiropractor, and a naturopath. They then categorised the distinct types of alternative healthcare practices into four groups: herbal and nutritional interventions, physical manipulative interventions (such as Reflexology and Chiropractic), mind-body interventions (like Hypnotherapy and Tai Chi), and alternative health or medicine belief systems (such as Homoeopathy and Traditional Chinese Medicine).
Once the team had established their panel of experts and grouped the alternative healthcare practices, they searched all the major electronic databases for legal cases, media reports, and journal articles that mentioned harm associated with the alternative therapies. They then compiled a list of the main types of harm, which the experts then reviewed, and after several rounds of analysis (the Delphi process), they were able to categorise the risks.
Not Without Risk
The team created a new functional definition of alternative healthcare and a taxonomy, a classification, of the risks. They grouped types of harm as direct (such as harm resulting from an alternative healthcare procedure) or indirect (resulting from replacing established medical care with an alternative therapy). They also assigned levels of risk as higher, moderate, or lower. They identified four major risk categories linked to the different types of alternative practice as well as general risks, such as the use of untested therapies or those that conflict with medical care.
Their report identified a considerable number of risks linked to alternative healthcare. Some serious adverse events were uncovered, including major physical injuries and even death. As Dr Garrett explains, there is a lack of a systematic method for recording adverse events in alternative medicine, which makes gathering data on the frequency of such events exceedingly difficult. He stresses that it is vital for people who engage with alternative healthcare to understand that it is not without risk, and that they should be clearly aware of what the risks might be.
Who Chooses Alternative Medicine, and Why?
In further research, the team explored why some people chose to engage In alternative medicine and explored the the implications for healthcare regulations and policy. Their study built on previous work on risk-associated alternative healthcare (RAAH) research. They carried out surveys to gather information about the characteristics of people who choose RAAH using several established psychometric tests: Control Beliefs Inventory (CBI), Reward Responsiveness Behavioural Activation System (RBAS) scale, Positive Attitudes to Science (PAS) scale, Satisfaction with Orthodox Medicine (SOM) scale, and the brief version of the Susceptibility to Persuasion-II (StP-II-B) scale – all which have been used in previous studies in predicting RAAH behaviours. They surveyed 2,253 members of the public (aged 16 years and over) and discounted 761 surveys that had missing information, meaning they had a final total of 1,492 respondents for analysis.
Several factors were found to influence RAAH, including age, gender, education, income, employment, ethnicity, and chronic illness status. The team reported that engagement with some forms of RAAH was quite common (at about 40% of those who were surveyed), with the most popular types of RAAH adopted being herbal remedy or supplement use, and physical manipulations. Around 5% of the respondents partook in higher-risk alternative healthcare activities, including dangerous physically invasive procedures and using known toxins.
Predicting Behaviours
The team reported that some of the psychometric tools they used were more useful than others. The StP-II-B and PAS instruments allowed prediction of the likelihood of a person choosing to engage with RAAH, highlighting factors such as a desire for novelty, a higher risk tolerance, and a positive attitude to advertising and social media. They found that the other tests, namely CBI, RBAS, and SOM, whilst not predictive overall, were still useful. The SOM and CBI tests were predictive of engaging with physically manipulative alternative therapies, and the RBAS was linked to herbal and nutritional supplementation use.
The team also noted that their study was the largest and most comprehensive investigation to date into alternative healthcare and risk in Canada. They identified engagement with RAAH as a significant health concern and propose that it highlights the importance of supporting evidence-based health policy and practice.
Dr Garrett explains that understanding how best to identify and educate members of the public on the significant risks linked to some alternative therapies is vital to health promotion. These findings can usefully inform health professionals’ understanding of health-seeking behaviours when it comes to risk, as well as public debate about the use of RAAH.
What is the Future of Alternative Therapies?
Alternative healthcare is often considered a safe, natural, and harmless option. It is clear this is not always the case. Serious injuries and fatalities can – and do – occur with alternative healthcare, just as they do with conventional medicine. Dr Garrett explains the potential to cause harm comes in many different forms, the most apparent being direct damage from a particular therapy, like a side effect from taking a herbal pill, but also less obvious harm, such as a supplement interacting with a cancer medication to make it less effective, or delaying conventional treatment leading to a worsening of a treatable condition. There are also other forms of harm, such as economic harm, when someone spends money on a treatment that is ineffective.
The work of Garrett, Caulfield, and colleagues highlights that there is still a lot of work to be done in terms of understanding risk in the ever-growing field of alternative healthcare. More insights are needed, especially into the use of alternative medicine in children. However, as the recording of adverse effects and harm remains largely unregulated, this is an ongoing challenge for researchers.
SHARE
DOWNLOAD E-BOOK
REFERENCE
https://doi.org/10.33548/SCIENTIA1080
MEET THE RESEARCHERS
Dr Bernie Garrett
School of Nursing
University of British Columbia
Vancouver
Canada
Dr Bernie Garrett completed a degree in Geography and became a Registered Nurse in 1987. He pursued a career as a renal Clinical Nurse Specialist, later becoming a nurse educator and researcher. He also holds a PhD in Information Science and a Postgraduate Certificate in Education. He is the Associate Director and Professor at the University of British Columbia (UBC) School of Nursing. In 2000, he received the College of Registered Nurses of BC Award of Excellence in Nursing Education and, in 2007, the Spencer Award for Information Technology Innovation. In 2013, he became the Elizabeth Kenny-McCann Nursing Education Scholar at UBC, and in 2014, the CASN Pat Griffin Nursing Education Scholar. He is also an Inaugural Fellow of the Canadian Nurse Educator Institute. Dr Garret has authored numerous papers and textbooks on health and nursing science, and is a frequent speaker at academic and public events, often contributing to popular media. His current research focuses on health science and deceptive healthcare practices, and he is the author of the critically acclaimed popular science book The New Alchemists: The Rise of Deceptive Healthcare.
CONTACT
E: Bernie.Garrett@ubc.ca
W: https://nursing.ubc.ca/our-people/bernie-garrett
X: @BernieGarrett
Professor Timothy Caulfield
Faculty of Law
Health Law Institute
University of Alberta
Edmonton
Canada
Professor Timothy Caulfield works in the Faculty of Law and the School of Public Health at the University of Alberta, where he is also the Research Director of the Health Law Institute. In 2002, he became the Canada Research Chair in Health Law and Policy and held this position for over two decades. He has received numerous academic and writing awards, and is a Member of the Order Canada and a Fellow of the Royal Society of Canada, the Canadian Academy of Health Sciences, and the Committee for Skeptical Inquiry. He has authored two national bestselling books and published nearly 400 academic articles. Professor Caulfield is the co-founder of the science engagement initiative #ScienceUpFirst, and the host and co-producer of the award-winning documentary A User’s Guide to Cheating Death, featured on Netflix. His work focuses on topics such as research ethics and public health, and his most recent publication is Relax, Dammit!: A User’s Guide to the Age of Anxiety.
CONTACT
E: caulfield@ualberta.ca
W: https://www.ualberta.ca/law/faculty-and-research/health-law-institute/people/timothycaulfield.html
FURTHER READING
B Garrett, T Caulfield, R Musoke, et al., Demographic and psychometric predictors associated with engagement in risk-associated alternative healthcare behaviours, 2023, PLoS ONE, 18(9), e0291016. DOI: https://doi.org/10.1371/journal.pone.0291016
B Garrett, T Caulfield, B Murdoch, et al., A taxonomy of risk-associated alternative health practices: A Delphi study, Health and Social Care in the Community, 2022, 30, 1163–1181. DOI: https://doi.org/10.1111/hsc.13386
REPUBLISH OUR ARTICLES
We encourage all formats of sharing and republishing of our articles. Whether you want to host on your website, publication or blog, we welcome this. Find out more
Creative Commons Licence (CC BY 4.0)
This work is licensed under a Creative Commons Attribution 4.0 International License.
What does this mean?
Share: You can copy and redistribute the material in any medium or format
Adapt: You can change, and build upon the material for any purpose, even commercially.
Credit: You must give appropriate credit, provide a link to the license, and indicate if changes were made.
SUBSCRIBE NOW
Follow Us
MORE ARTICLES YOU MAY LIKE
Professor Rajgopal Govindarajan | The Role of CNT1 Nucleoside Transporter in Nucleotide Homeostasis
A supply of nucleotides is necessary to sustain the body’s genetic and metabolic processes. CNT1, a nucleoside transporter, is instrumental in preventing nucleoside excretion. Professor Rajgopal (Raj) Govindarajan at Ohio State University is delving into CNT1’s in vivo activity, utilising mouse models, mass spectrometry, and metabolomics tools. His research has important implications for cancer therapy.
Dr Helen Marsden | DERM: A Novel Device to Detect Skin Cancer
Skin cancer affects millions around the world and is among the most commonly occurring cancers. This global impact leads to an ever-growing demand for dermatology capacity, which is simply not available. Given that skin cancer can be treatable with high rates of survival when detected early, technology interventions are required to address the gap between demand and capacity. Dr Helen Marsden conducts vital research at Skin Analytics Ltd to demonstrate how AI can allow dermatology teams to discharge benign lesions earlier in the pathway and help prioritise patients who need to be seen or receive treatment.
Dr. David Minor | Immunotherapy Treatments for Skin Cancer Boost Long-Term Survival Rates
Immunotherapy has changed the face of cancer treatment, particularly for those suffering from advanced skin cancers. With plenty yet to be learnt in this field of medicine, Dr. David Minor and his colleagues based at the California Pacific Medical Center Research Institute and the California Pacific Center for Melanoma Research and Treatment explore the long-term impact of immunotherapy on advanced skin cancer survivors.
Dr Matthew Williams | Personality and Pain: The Role of Personality Traits in Musculoskeletal Rehabilitation
The interactions between body functions, mental processes, and the social environment are critical in healthcare but all too often not fully understood. For example, the field of musculoskeletal health involves treatment of the muscles, bones, joints, and connective tissues that support and move the body. Whilst clinicians are great at evaluating the physiological aspects of musculoskeletal problems, they often miss how an individual’s psychological factors can influence treatment outcomes. Dr Matthew Williams, at Baylor University in the USA, is pioneering the application of personality psychology to musculoskeletal intervention strategies.